nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP3A4—Thiotepa—urinary bladder cancer	0.0948	0.386	CbGbCtD
Aminoglutethimide—CYP1A2—Fluorouracil—urinary bladder cancer	0.0588	0.239	CbGbCtD
Aminoglutethimide—CYP1A2—Etoposide—urinary bladder cancer	0.0491	0.2	CbGbCtD
Aminoglutethimide—CYP3A4—Etoposide—urinary bladder cancer	0.0257	0.105	CbGbCtD
Aminoglutethimide—CYP3A4—Doxorubicin—urinary bladder cancer	0.0175	0.0713	CbGbCtD
Aminoglutethimide—Alveolitis allergic—Methotrexate—urinary bladder cancer	0.00985	0.0266	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Thiotepa—urinary bladder cancer	0.00931	0.0252	CcSEcCtD
Aminoglutethimide—Pancytopenia—Mitomycin—urinary bladder cancer	0.00708	0.0191	CcSEcCtD
Aminoglutethimide—Anaemia—Valrubicin—urinary bladder cancer	0.00697	0.0188	CcSEcCtD
Aminoglutethimide—Haematocrit decreased—Methotrexate—urinary bladder cancer	0.0069	0.0187	CcSEcCtD
Aminoglutethimide—Drowsiness—Mitomycin—urinary bladder cancer	0.00664	0.018	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Gemcitabine—urinary bladder cancer	0.00651	0.0176	CcSEcCtD
Aminoglutethimide—CYP2C19—urine—urinary bladder cancer	0.00642	0.225	CbGeAlD
Aminoglutethimide—Myalgia—Valrubicin—urinary bladder cancer	0.00642	0.0174	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Cisplatin—urinary bladder cancer	0.00607	0.0164	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0056	0.0152	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Etoposide—urinary bladder cancer	0.00556	0.015	CcSEcCtD
Aminoglutethimide—CYP1A2—urine—urinary bladder cancer	0.00524	0.184	CbGeAlD
Aminoglutethimide—Body temperature increased—Valrubicin—urinary bladder cancer	0.00486	0.0132	CcSEcCtD
Aminoglutethimide—Anaemia—Mitomycin—urinary bladder cancer	0.0048	0.013	CcSEcCtD
Aminoglutethimide—Leukopenia—Mitomycin—urinary bladder cancer	0.00465	0.0126	CcSEcCtD
Aminoglutethimide—Body temperature increased—Carboplatin—urinary bladder cancer	0.0045	0.0122	CcSEcCtD
Aminoglutethimide—Pruritus—Valrubicin—urinary bladder cancer	0.00435	0.0118	CcSEcCtD
Aminoglutethimide—Dizziness—Valrubicin—urinary bladder cancer	0.00407	0.011	CcSEcCtD
Aminoglutethimide—Anorexia—Mitomycin—urinary bladder cancer	0.00404	0.0109	CcSEcCtD
Aminoglutethimide—Vomiting—Valrubicin—urinary bladder cancer	0.00391	0.0106	CcSEcCtD
Aminoglutethimide—Rash—Valrubicin—urinary bladder cancer	0.00388	0.0105	CcSEcCtD
Aminoglutethimide—Dermatitis—Valrubicin—urinary bladder cancer	0.00387	0.0105	CcSEcCtD
Aminoglutethimide—Headache—Valrubicin—urinary bladder cancer	0.00385	0.0104	CcSEcCtD
Aminoglutethimide—CYP3A4—urine—urinary bladder cancer	0.00379	0.133	CbGeAlD
Aminoglutethimide—Somnolence—Mitomycin—urinary bladder cancer	0.00377	0.0102	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.00377	0.0102	CcSEcCtD
Aminoglutethimide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00368	0.00997	CcSEcCtD
Aminoglutethimide—Nausea—Valrubicin—urinary bladder cancer	0.00365	0.00989	CcSEcCtD
Aminoglutethimide—Pancytopenia—Thiotepa—urinary bladder cancer	0.00356	0.00963	CcSEcCtD
Aminoglutethimide—Body temperature increased—Mitomycin—urinary bladder cancer	0.00335	0.00906	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Methotrexate—urinary bladder cancer	0.00333	0.00901	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00312	0.00844	CcSEcCtD
Aminoglutethimide—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00299	0.0081	CcSEcCtD
Aminoglutethimide—Neutropenia—Gemcitabine—urinary bladder cancer	0.00295	0.00798	CcSEcCtD
Aminoglutethimide—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00294	0.00796	CcSEcCtD
Aminoglutethimide—CYP19A1—prostate gland—urinary bladder cancer	0.00281	0.0984	CbGeAlD
Aminoglutethimide—Dizziness—Mitomycin—urinary bladder cancer	0.0028	0.00758	CcSEcCtD
Aminoglutethimide—Pancytopenia—Cisplatin—urinary bladder cancer	0.00279	0.00755	CcSEcCtD
Aminoglutethimide—Vomiting—Mitomycin—urinary bladder cancer	0.00269	0.00729	CcSEcCtD
Aminoglutethimide—Rash—Mitomycin—urinary bladder cancer	0.00267	0.00723	CcSEcCtD
Aminoglutethimide—Dermatitis—Mitomycin—urinary bladder cancer	0.00267	0.00722	CcSEcCtD
Aminoglutethimide—Headache—Mitomycin—urinary bladder cancer	0.00265	0.00718	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00262	0.0071	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00258	0.00698	CcSEcCtD
Aminoglutethimide—Pancytopenia—Etoposide—urinary bladder cancer	0.00256	0.00692	CcSEcCtD
Aminoglutethimide—Neutropenia—Etoposide—urinary bladder cancer	0.00252	0.00681	CcSEcCtD
Aminoglutethimide—Nausea—Mitomycin—urinary bladder cancer	0.00252	0.00681	CcSEcCtD
Aminoglutethimide—Anaemia—Thiotepa—urinary bladder cancer	0.00241	0.00653	CcSEcCtD
Aminoglutethimide—CYP11A1—female reproductive system—urinary bladder cancer	0.00236	0.0827	CbGeAlD
Aminoglutethimide—Leukopenia—Thiotepa—urinary bladder cancer	0.00234	0.00632	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00224	0.00606	CcSEcCtD
Aminoglutethimide—Myalgia—Thiotepa—urinary bladder cancer	0.00222	0.00602	CcSEcCtD
Aminoglutethimide—Tachycardia—Thiotepa—urinary bladder cancer	0.00208	0.00563	CcSEcCtD
Aminoglutethimide—Anorexia—Thiotepa—urinary bladder cancer	0.00203	0.0055	CcSEcCtD
Aminoglutethimide—Anaemia—Gemcitabine—urinary bladder cancer	0.00203	0.00549	CcSEcCtD
Aminoglutethimide—Anaemia—Fluorouracil—urinary bladder cancer	0.002	0.0054	CcSEcCtD
Aminoglutethimide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00197	0.00532	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00194	0.00525	CcSEcCtD
Aminoglutethimide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00193	0.00523	CcSEcCtD
Aminoglutethimide—Somnolence—Thiotepa—urinary bladder cancer	0.00189	0.00513	CcSEcCtD
Aminoglutethimide—Anaemia—Cisplatin—urinary bladder cancer	0.00189	0.00512	CcSEcCtD
Aminoglutethimide—Myalgia—Gemcitabine—urinary bladder cancer	0.00187	0.00506	CcSEcCtD
Aminoglutethimide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00185	0.00501	CcSEcCtD
Aminoglutethimide—Myalgia—Fluorouracil—urinary bladder cancer	0.00184	0.00498	CcSEcCtD
Aminoglutethimide—Leukopenia—Cisplatin—urinary bladder cancer	0.00183	0.00496	CcSEcCtD
Aminoglutethimide—Myalgia—Cisplatin—urinary bladder cancer	0.00174	0.00472	CcSEcCtD
Aminoglutethimide—Anaemia—Etoposide—urinary bladder cancer	0.00173	0.00469	CcSEcCtD
Aminoglutethimide—Tachycardia—Fluorouracil—urinary bladder cancer	0.00172	0.00465	CcSEcCtD
Aminoglutethimide—Anorexia—Gemcitabine—urinary bladder cancer	0.00171	0.00462	CcSEcCtD
Aminoglutethimide—Urticaria—Thiotepa—urinary bladder cancer	0.00169	0.00458	CcSEcCtD
Aminoglutethimide—Body temperature increased—Thiotepa—urinary bladder cancer	0.00168	0.00456	CcSEcCtD
Aminoglutethimide—Anorexia—Fluorouracil—urinary bladder cancer	0.00168	0.00455	CcSEcCtD
Aminoglutethimide—Leukopenia—Etoposide—urinary bladder cancer	0.00168	0.00454	CcSEcCtD
Aminoglutethimide—Hypotension—Gemcitabine—urinary bladder cancer	0.00168	0.00453	CcSEcCtD
Aminoglutethimide—Hypotension—Fluorouracil—urinary bladder cancer	0.00165	0.00446	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00163	0.00442	CcSEcCtD
Aminoglutethimide—Tachycardia—Cisplatin—urinary bladder cancer	0.00163	0.00441	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00161	0.00435	CcSEcCtD
Aminoglutethimide—Somnolence—Gemcitabine—urinary bladder cancer	0.00159	0.00431	CcSEcCtD
Aminoglutethimide—Anorexia—Cisplatin—urinary bladder cancer	0.00159	0.00431	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00157	0.00425	CcSEcCtD
Aminoglutethimide—Somnolence—Fluorouracil—urinary bladder cancer	0.00157	0.00424	CcSEcCtD
Aminoglutethimide—Hypotension—Cisplatin—urinary bladder cancer	0.00156	0.00422	CcSEcCtD
Aminoglutethimide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00156	0.00422	CcSEcCtD
Aminoglutethimide—CYP19A1—female reproductive system—urinary bladder cancer	0.00153	0.0537	CbGeAlD
Aminoglutethimide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00153	0.00415	CcSEcCtD
Aminoglutethimide—Pancytopenia—Methotrexate—urinary bladder cancer	0.00153	0.00414	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00152	0.00412	CcSEcCtD
Aminoglutethimide—Neutropenia—Methotrexate—urinary bladder cancer	0.00151	0.00408	CcSEcCtD
Aminoglutethimide—Pruritus—Thiotepa—urinary bladder cancer	0.00151	0.00408	CcSEcCtD
Aminoglutethimide—Tachycardia—Etoposide—urinary bladder cancer	0.00149	0.00404	CcSEcCtD
Aminoglutethimide—Anorexia—Etoposide—urinary bladder cancer	0.00146	0.00395	CcSEcCtD
Aminoglutethimide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00145	0.00393	CcSEcCtD
Aminoglutethimide—Drowsiness—Methotrexate—urinary bladder cancer	0.00144	0.00389	CcSEcCtD
Aminoglutethimide—Pancytopenia—Epirubicin—urinary bladder cancer	0.00143	0.00388	CcSEcCtD
Aminoglutethimide—Hypotension—Etoposide—urinary bladder cancer	0.00143	0.00387	CcSEcCtD
Aminoglutethimide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00142	0.00383	CcSEcCtD
Aminoglutethimide—Neutropenia—Epirubicin—urinary bladder cancer	0.00141	0.00382	CcSEcCtD
Aminoglutethimide—Dizziness—Thiotepa—urinary bladder cancer	0.00141	0.00381	CcSEcCtD
Aminoglutethimide—Urticaria—Fluorouracil—urinary bladder cancer	0.0014	0.00379	CcSEcCtD
Aminoglutethimide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00139	0.00377	CcSEcCtD
Aminoglutethimide—CYP11A1—lymph node—urinary bladder cancer	0.00138	0.0484	CbGeAlD
Aminoglutethimide—Somnolence—Etoposide—urinary bladder cancer	0.00136	0.00368	CcSEcCtD
Aminoglutethimide—Vomiting—Thiotepa—urinary bladder cancer	0.00136	0.00367	CcSEcCtD
Aminoglutethimide—Drowsiness—Epirubicin—urinary bladder cancer	0.00135	0.00364	CcSEcCtD
Aminoglutethimide—Rash—Thiotepa—urinary bladder cancer	0.00134	0.00364	CcSEcCtD
Aminoglutethimide—Dermatitis—Thiotepa—urinary bladder cancer	0.00134	0.00363	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00134	0.00363	CcSEcCtD
Aminoglutethimide—Headache—Thiotepa—urinary bladder cancer	0.00134	0.00361	CcSEcCtD
Aminoglutethimide—Decreased appetite—Etoposide—urinary bladder cancer	0.00133	0.0036	CcSEcCtD
Aminoglutethimide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00133	0.00359	CcSEcCtD
Aminoglutethimide—Body temperature increased—Cisplatin—urinary bladder cancer	0.00132	0.00357	CcSEcCtD
Aminoglutethimide—Neutropenia—Doxorubicin—urinary bladder cancer	0.00131	0.00353	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0013	0.00351	CcSEcCtD
Aminoglutethimide—CYP1A2—renal system—urinary bladder cancer	0.00128	0.045	CbGeAlD
Aminoglutethimide—Pruritus—Gemcitabine—urinary bladder cancer	0.00127	0.00343	CcSEcCtD
Aminoglutethimide—Nausea—Thiotepa—urinary bladder cancer	0.00127	0.00343	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00126	0.0034	CcSEcCtD
Aminoglutethimide—Pruritus—Fluorouracil—urinary bladder cancer	0.00125	0.00337	CcSEcCtD
Aminoglutethimide—Drowsiness—Doxorubicin—urinary bladder cancer	0.00124	0.00337	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00123	0.00333	CcSEcCtD
Aminoglutethimide—Urticaria—Etoposide—urinary bladder cancer	0.00122	0.00329	CcSEcCtD
Aminoglutethimide—Body temperature increased—Etoposide—urinary bladder cancer	0.00121	0.00327	CcSEcCtD
Aminoglutethimide—Dizziness—Fluorouracil—urinary bladder cancer	0.00117	0.00315	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00116	0.00314	CcSEcCtD
Aminoglutethimide—Vomiting—Gemcitabine—urinary bladder cancer	0.00114	0.00308	CcSEcCtD
Aminoglutethimide—CYP2C19—vagina—urinary bladder cancer	0.00114	0.0399	CbGeAlD
Aminoglutethimide—Rash—Gemcitabine—urinary bladder cancer	0.00113	0.00306	CcSEcCtD
Aminoglutethimide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00113	0.00306	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Etoposide—urinary bladder cancer	0.00113	0.00305	CcSEcCtD
Aminoglutethimide—Headache—Gemcitabine—urinary bladder cancer	0.00112	0.00304	CcSEcCtD
Aminoglutethimide—Vomiting—Fluorouracil—urinary bladder cancer	0.00112	0.00303	CcSEcCtD
Aminoglutethimide—Rash—Fluorouracil—urinary bladder cancer	0.00111	0.00301	CcSEcCtD
Aminoglutethimide—Dermatitis—Fluorouracil—urinary bladder cancer	0.00111	0.003	CcSEcCtD
Aminoglutethimide—Headache—Fluorouracil—urinary bladder cancer	0.0011	0.00299	CcSEcCtD
Aminoglutethimide—Pruritus—Etoposide—urinary bladder cancer	0.00108	0.00293	CcSEcCtD
Aminoglutethimide—Nausea—Gemcitabine—urinary bladder cancer	0.00106	0.00288	CcSEcCtD
Aminoglutethimide—Vomiting—Cisplatin—urinary bladder cancer	0.00106	0.00287	CcSEcCtD
Aminoglutethimide—Rash—Cisplatin—urinary bladder cancer	0.00105	0.00285	CcSEcCtD
Aminoglutethimide—Dermatitis—Cisplatin—urinary bladder cancer	0.00105	0.00285	CcSEcCtD
Aminoglutethimide—Nausea—Fluorouracil—urinary bladder cancer	0.00105	0.00283	CcSEcCtD
Aminoglutethimide—Anaemia—Methotrexate—urinary bladder cancer	0.00104	0.00281	CcSEcCtD
Aminoglutethimide—Dizziness—Etoposide—urinary bladder cancer	0.00101	0.00274	CcSEcCtD
Aminoglutethimide—Leukopenia—Methotrexate—urinary bladder cancer	0.00101	0.00272	CcSEcCtD
Aminoglutethimide—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.001	0.00281	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.001	0.00281	CbGpPWpGaD
Aminoglutethimide—Nausea—Cisplatin—urinary bladder cancer	0.000993	0.00269	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000988	0.00278	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CXCL8—urinary bladder cancer	0.000976	0.00274	CbGpPWpGaD
Aminoglutethimide—Vomiting—Etoposide—urinary bladder cancer	0.000973	0.00263	CcSEcCtD
Aminoglutethimide—Anaemia—Epirubicin—urinary bladder cancer	0.000972	0.00263	CcSEcCtD
Aminoglutethimide—Rash—Etoposide—urinary bladder cancer	0.000965	0.00261	CcSEcCtD
Aminoglutethimide—Dermatitis—Etoposide—urinary bladder cancer	0.000964	0.00261	CcSEcCtD
Aminoglutethimide—Headache—Etoposide—urinary bladder cancer	0.000959	0.00259	CcSEcCtD
Aminoglutethimide—Myalgia—Methotrexate—urinary bladder cancer	0.000957	0.00259	CcSEcCtD
Aminoglutethimide—Leukopenia—Epirubicin—urinary bladder cancer	0.000941	0.00255	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000938	0.00264	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—IL2—urinary bladder cancer	0.000933	0.00262	CbGpPWpGaD
Aminoglutethimide—CYP3A4—renal system—urinary bladder cancer	0.000928	0.0325	CbGeAlD
Aminoglutethimide—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000916	0.00257	CbGpPWpGaD
Aminoglutethimide—Nausea—Etoposide—urinary bladder cancer	0.000909	0.00246	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000904	0.00254	CbGpPWpGaD
Aminoglutethimide—Anaemia—Doxorubicin—urinary bladder cancer	0.000899	0.00243	CcSEcCtD
Aminoglutethimide—CYP19A1—lymph node—urinary bladder cancer	0.000897	0.0314	CbGeAlD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000895	0.00252	CbGpPWpGaD
Aminoglutethimide—Myalgia—Epirubicin—urinary bladder cancer	0.000895	0.00242	CcSEcCtD
Aminoglutethimide—Anorexia—Methotrexate—urinary bladder cancer	0.000874	0.00236	CcSEcCtD
Aminoglutethimide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000871	0.00236	CcSEcCtD
Aminoglutethimide—Hypotension—Methotrexate—urinary bladder cancer	0.000857	0.00232	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000838	0.00235	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Epirubicin—urinary bladder cancer	0.000838	0.00227	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000835	0.00226	CcSEcCtD
Aminoglutethimide—Myalgia—Doxorubicin—urinary bladder cancer	0.000828	0.00224	CcSEcCtD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000825	0.00232	CbGpPWpGaD
Aminoglutethimide—Anorexia—Epirubicin—urinary bladder cancer	0.000818	0.00221	CcSEcCtD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000816	0.00229	CbGpPWpGaD
Aminoglutethimide—Somnolence—Methotrexate—urinary bladder cancer	0.000815	0.00221	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000814	0.00229	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000804	0.00226	CbGpPWpGaD
Aminoglutethimide—Hypotension—Epirubicin—urinary bladder cancer	0.000802	0.00217	CcSEcCtD
Aminoglutethimide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000797	0.00216	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000782	0.00212	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00078	0.00219	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000775	0.0021	CcSEcCtD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000773	0.00217	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000773	0.00217	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000769	0.00216	CbGpPWpGaD
Aminoglutethimide—Somnolence—Epirubicin—urinary bladder cancer	0.000763	0.00206	CcSEcCtD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000763	0.00214	CbGpPWpGaD
Aminoglutethimide—Anorexia—Doxorubicin—urinary bladder cancer	0.000757	0.00205	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.00075	0.00211	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000746	0.00202	CcSEcCtD
Aminoglutethimide—CYP3A4—female reproductive system—urinary bladder cancer	0.000744	0.0261	CbGeAlD
Aminoglutethimide—Hypotension—Doxorubicin—urinary bladder cancer	0.000742	0.00201	CcSEcCtD
Aminoglutethimide—Urticaria—Methotrexate—urinary bladder cancer	0.000728	0.00197	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000728	0.00204	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000725	0.00196	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000723	0.00196	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—GSTZ1—urinary bladder cancer	0.000721	0.00203	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000717	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000711	0.002	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000707	0.00199	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000707	0.00199	CbGpPWpGaD
Aminoglutethimide—Somnolence—Doxorubicin—urinary bladder cancer	0.000706	0.00191	CcSEcCtD
Aminoglutethimide—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000704	0.00198	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000698	0.00196	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000697	0.00196	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000695	0.00195	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00069	0.00187	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—GSTO2—urinary bladder cancer	0.000684	0.00192	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NAT1—urinary bladder cancer	0.000684	0.00192	CbGpPWpGaD
Aminoglutethimide—Urticaria—Epirubicin—urinary bladder cancer	0.000682	0.00184	CcSEcCtD
Aminoglutethimide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000678	0.00184	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000676	0.00183	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000673	0.00189	CbGpPWpGaD
Aminoglutethimide—Pruritus—Methotrexate—urinary bladder cancer	0.000649	0.00176	CcSEcCtD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000637	0.00179	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000632	0.00171	CcSEcCtD
Aminoglutethimide—Urticaria—Doxorubicin—urinary bladder cancer	0.000631	0.00171	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00063	0.00177	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000628	0.00176	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000628	0.0017	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000628	0.00176	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—UGT2B7—urinary bladder cancer	0.000626	0.00176	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000625	0.00176	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000612	0.00172	CbGpPWpGaD
Aminoglutethimide—Pruritus—Epirubicin—urinary bladder cancer	0.000607	0.00164	CcSEcCtD
Aminoglutethimide—Dizziness—Methotrexate—urinary bladder cancer	0.000606	0.00164	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000585	0.00158	CcSEcCtD
Aminoglutethimide—Vomiting—Methotrexate—urinary bladder cancer	0.000583	0.00158	CcSEcCtD
Aminoglutethimide—Rash—Methotrexate—urinary bladder cancer	0.000578	0.00156	CcSEcCtD
Aminoglutethimide—Dermatitis—Methotrexate—urinary bladder cancer	0.000578	0.00156	CcSEcCtD
Aminoglutethimide—Headache—Methotrexate—urinary bladder cancer	0.000574	0.00155	CcSEcCtD
Aminoglutethimide—Dizziness—Epirubicin—urinary bladder cancer	0.000567	0.00154	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—CYP4B1—urinary bladder cancer	0.000563	0.00158	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000563	0.00158	CbGpPWpGaD
Aminoglutethimide—Pruritus—Doxorubicin—urinary bladder cancer	0.000562	0.00152	CcSEcCtD
Aminoglutethimide—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000549	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000548	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000546	0.00153	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000546	0.00153	CbGpPWpGaD
Aminoglutethimide—Vomiting—Epirubicin—urinary bladder cancer	0.000546	0.00148	CcSEcCtD
Aminoglutethimide—Nausea—Methotrexate—urinary bladder cancer	0.000545	0.00147	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000544	0.00153	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000541	0.00152	CbGpPWpGaD
Aminoglutethimide—Rash—Epirubicin—urinary bladder cancer	0.000541	0.00146	CcSEcCtD
Aminoglutethimide—Dermatitis—Epirubicin—urinary bladder cancer	0.000541	0.00146	CcSEcCtD
Aminoglutethimide—Headache—Epirubicin—urinary bladder cancer	0.000538	0.00145	CcSEcCtD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000534	0.0015	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SLC19A1—urinary bladder cancer	0.000532	0.00149	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000527	0.00148	CbGpPWpGaD
Aminoglutethimide—Dizziness—Doxorubicin—urinary bladder cancer	0.000525	0.00142	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—PRSS3—urinary bladder cancer	0.000518	0.00146	CbGpPWpGaD
Aminoglutethimide—Nausea—Epirubicin—urinary bladder cancer	0.00051	0.00138	CcSEcCtD
Aminoglutethimide—Vomiting—Doxorubicin—urinary bladder cancer	0.000505	0.00137	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000504	0.00142	CbGpPWpGaD
Aminoglutethimide—Rash—Doxorubicin—urinary bladder cancer	0.000501	0.00135	CcSEcCtD
Aminoglutethimide—Dermatitis—Doxorubicin—urinary bladder cancer	0.0005	0.00135	CcSEcCtD
Aminoglutethimide—Headache—Doxorubicin—urinary bladder cancer	0.000497	0.00135	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.000478	0.00134	CbGpPWpGaD
Aminoglutethimide—Nausea—Doxorubicin—urinary bladder cancer	0.000472	0.00128	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000463	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.000453	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.000453	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000446	0.00125	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000439	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000439	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000426	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000424	0.00119	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000418	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000416	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—TYMP—urinary bladder cancer	0.000414	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000414	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000411	0.00115	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000407	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000407	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000405	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000398	0.00112	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000391	0.0011	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000384	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000379	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NAT2—urinary bladder cancer	0.000375	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000373	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000373	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000373	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000365	0.00103	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000365	0.00103	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000355	0.000998	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000355	0.000998	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000352	0.00099	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000348	0.000978	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000343	0.000965	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000343	0.000964	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000339	0.000952	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000328	0.000923	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000325	0.000913	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—RRM2—urinary bladder cancer	0.000323	0.000909	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000318	0.000894	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000318	0.000893	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000317	0.00089	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000311	0.000874	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000311	0.000874	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.0003	0.000844	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—HPGDS—urinary bladder cancer	0.0003	0.000842	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ENO2—urinary bladder cancer	0.0003	0.000842	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000298	0.000837	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000296	0.000833	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000296	0.000833	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000295	0.000829	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000294	0.000826	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000291	0.000818	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTT1—urinary bladder cancer	0.000291	0.000817	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000286	0.000804	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000275	0.000774	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000275	0.000771	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000271	0.000762	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000267	0.000751	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000267	0.00075	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000264	0.000741	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.00025	0.000702	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.000248	0.000698	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NQO1—urinary bladder cancer	0.000241	0.000679	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000234	0.000658	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000232	0.000652	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000228	0.00064	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000225	0.000631	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.00022	0.000618	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.00022	0.000618	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000216	0.000608	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000214	0.000602	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000209	0.000588	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000206	0.00058	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000204	0.000574	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTP1—urinary bladder cancer	0.000201	0.000566	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000201	0.000565	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.000198	0.000558	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.000198	0.000558	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000197	0.000554	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000195	0.000548	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000192	0.000541	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00019	0.000533	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—TYMS—urinary bladder cancer	0.000187	0.000526	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NCOR1—urinary bladder cancer	0.000185	0.00052	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTM1—urinary bladder cancer	0.000185	0.00052	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	0.000181	0.000509	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000181	0.000508	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GPX1—urinary bladder cancer	0.000177	0.000498	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ERCC2—urinary bladder cancer	0.000174	0.000489	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000171	0.000481	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000171	0.000481	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	0.000171	0.00048	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000169	0.000473	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	0.000167	0.000468	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—MTHFR—urinary bladder cancer	0.000164	0.00046	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.00016	0.00045	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000157	0.00044	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000155	0.000436	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000141	0.000396	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000139	0.000392	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000135	0.00038	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000134	0.000375	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000133	0.000375	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000133	0.000374	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	0.000133	0.000374	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PPARG—urinary bladder cancer	0.000133	0.000373	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	0.000132	0.000372	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	0.000132	0.000372	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.00013	0.000365	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000129	0.000363	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000128	0.00036	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CREBBP—urinary bladder cancer	0.000127	0.000358	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000124	0.000349	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000123	0.000345	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000123	0.000345	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.00034	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	0.00012	0.000339	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000117	0.00033	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000115	0.000324	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.000306	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.000108	0.000304	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	0.000104	0.000293	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000104	0.000293	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	0.000104	0.000292	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TYMP—urinary bladder cancer	0.000104	0.000292	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.000289	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	0.0001	0.000282	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.97e-05	0.00028	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	9.63e-05	0.000271	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	9.63e-05	0.000271	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.57e-05	0.000269	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NAT2—urinary bladder cancer	9.39e-05	0.000264	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	9.34e-05	0.000262	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.2e-05	0.000258	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTEN—urinary bladder cancer	9.1e-05	0.000256	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PPARG—urinary bladder cancer	8.79e-05	0.000247	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—EP300—urinary bladder cancer	8.68e-05	0.000244	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	8.44e-05	0.000237	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RRM2—urinary bladder cancer	8.1e-05	0.000228	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	8.01e-05	0.000225	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	7.76e-05	0.000218	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.53e-05	0.000212	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	7.5e-05	0.000211	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ENO2—urinary bladder cancer	7.5e-05	0.000211	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.46e-05	0.00021	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	7.28e-05	0.000205	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	7.24e-05	0.000204	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.17e-05	0.000201	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	6.91e-05	0.000194	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.57e-05	0.000185	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	6.47e-05	0.000182	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.26e-05	0.000176	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	6.25e-05	0.000176	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NQO1—urinary bladder cancer	6.05e-05	0.00017	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTEN—urinary bladder cancer	6.03e-05	0.000169	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	6.02e-05	0.000169	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.95e-05	0.000167	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.95e-05	0.000167	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.87e-05	0.000165	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.79e-05	0.000163	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.79e-05	0.000163	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—EP300—urinary bladder cancer	5.75e-05	0.000162	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	5.7e-05	0.00016	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.62e-05	0.000158	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	5.59e-05	0.000157	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	5.26e-05	0.000148	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.12e-05	0.000144	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.05e-05	0.000142	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.88e-05	0.000137	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.69e-05	0.000132	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.67e-05	0.000131	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.64e-05	0.00013	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.64e-05	0.00013	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GPX1—urinary bladder cancer	4.44e-05	0.000125	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	4.36e-05	0.000122	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	4.26e-05	0.00012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.1e-05	0.000115	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	4.1e-05	0.000115	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.89e-05	0.000109	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.62e-05	0.000102	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.58e-05	0.000101	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.58e-05	0.000101	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.43e-05	9.63e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.36e-05	9.45e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.35e-05	9.43e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.32e-05	9.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.19e-05	8.97e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.16e-05	8.89e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.93e-05	8.22e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.79e-05	7.84e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.61e-05	7.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.56e-05	7.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.46e-05	6.92e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.28e-05	6.4e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.17e-05	6.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.02e-05	5.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.76e-05	4.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.68e-05	4.71e-05	CbGpPWpGaD
